StockData
Pelthos Therapeutics Inc. logo

Pelthos Therapeutics Inc. (PTHS) stock

PTHSNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$7.10+0.26 (+3.80%)

Close on Nov 18, 2026Market cap $27.18MP/E –Yield –

Pelthos Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Pelthos Therapeutics's price to book ratio was 5.0× on Jul 31, 2026.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20265.0×+3.4
2025Dec 31, 20251.6×−3.8
2024Jul 31, 20245.5×–

More Pelthos Therapeutics figures

See a number that looks wrong?